V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009649 | 270005710 | 1.58 | 39.4 | Neo-adjuvant (N) | 2014-08-23 | 2014-08-23 | null | 2 | N | 270019941 | GEMCARBO |
| 270009650 | 270012819 | 1.75 | 60.8 | Neo-adjuvant (N) | 2016-06-24 | 2016-07-02 | CAPECITABINE + CARBOPLATIN | 2 | N | 270019943 | ENZALUTAMIDE |
| 270009651 | 270016023 | 1.74 | 61.7 | Curative (C) | 2013-02-24 | 2013-02-24 | Rituximab | N | N | 270019944 | CHOP |
| 270009652 | 270016023 | 1.74 | 69.1 | Palliative (P) | 2017-08-03 | 2017-08-08 | CETUXIMAB | N | N | 270019944 | GEMCITABINE + NAB-PACLITAXEL |
| 270009653 | 270018887 | 1.81 | 70.6 | Curative (C) | 2015-05-05 | 2015-05-10 | CETUXIMAB | N | N | 270019948 | NOT MATCHED |
| 270009654 | 270005711 | 1.7 | 47.8 | null | 2017-03-07 | 2017-03-25 | Cetuximab + Radiotherapy Load | N | N | 270019954 | CETUXIMAB + RT |
| 270009655 | 270005712 | 1.66 | 113 | Palliative (P) | 2014-03-31 | 2015-04-27 | Cetuximab 14 day | N | N | 270019958 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009656 | 270012820 | 1.67 | 102.2 | Curative (C) | 2013-04-11 | 2013-04-11 | CARBOPLATIN + RT | 2 | N | 270019972 | CETUXIMAB + RT |
| 270009657 | 270012820 | 1.58 | null | Curative (C) | 2016-02-11 | 2016-02-12 | Docetaxel | N | N | 270019972 | CARBOPLATIN + RT |
| 270009658 | 270012820 | 1.7 | 75.1 | Palliative (P) | 2016-01-04 | 2016-01-04 | Cetuximab + FOLFIRI cycle1 | null | null | 270019972 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009659 | 270012820 | 1.42 | 0 | Curative (C) | 2014-10-17 | 2014-10-17 | Cetuximab + Radiotherapy Load | N | N | 270019972 | CETUXIMAB + RT |
| 270009660 | 270012820 | 1.8 | 84 | null | 2014-12-08 | 2014-12-08 | SCOT TRIAL | 02 | N | 270019972 | CETUXIMAB + RT |
| 270009661 | 270005713 | 1.82 | 76.6 | Curative (C) | null | 2017-10-24 | Trastuzumab 21 day maintenance | N | N | 270019995 | CISPLATIN + ETOPOSIDE |
| 270009662 | 270005714 | 1.7 | 98 | Palliative (P) | 2013-06-13 | 2013-07-11 | Folfirinox | N | N | 270019996 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270009663 | 270005715 | 1.62 | 100 | Palliative (P) | 2017-01-01 | 2017-01-09 | Gemcitabine + Capecitabine | N | N | 270019998 | CETUXIMAB + RT |
| 270009664 | 270005715 | 1.82 | 93 | Palliative (P) | 2017-02-13 | 2017-02-16 | Cetuximab + Radiotherapy Load | N | N | 270019998 | CARBO + FLUOROURACIL |
| 270009665 | 270016025 | 1.85 | 71.4 | Curative (C) | 2016-04-28 | 2016-05-01 | Carboplatin + Etoposide IV 3 day | N | N | 270020011 | OXALIPLATIN |
| 270009666 | 270016025 | 1.72 | 102.2 | Palliative (P) | 2014-03-03 | 2014-04-01 | Cisplatin + Vinorelbine (IV) | 2 | N | 270020011 | CISPLATIN + VINORELBINE |
| 270009667 | 270018889 | 1.52 | 51.5 | Palliative (P) | 2014-05-12 | 2014-06-09 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | null | 270020024 | CUFOX TRIAL |
| 270009668 | 270005716 | null | null | Curative (C) | null | 2015-05-01 | Carboplatin + Vinorelbine IV | null | null | 270020028 | CARBOPLATIN + VINORELBINE |
| 270009669 | 270005716 | null | 50.5 | Palliative (P) | 2016-10-10 | 2016-10-31 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | N | 270020028 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270009670 | 270005716 | 1.69 | null | Palliative (P) | 2014-03-19 | 2014-04-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 270020028 | CETUXIMAB + IRINOTECAN + MDG |
| 270009671 | 270005717 | 1.73 | 77.7 | Curative (C) | 2017-10-12 | 2017-10-18 | Capecitabine (14 days)+Carboplatin | null | N | 270020036 | ENZALUTAMIDE |
| 270009672 | 270005717 | null | null | Neo-adjuvant (N) | 2014-09-13 | 2014-09-14 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 270020036 | CETUXIMAB |
| 270009673 | 270005717 | 1.67 | 89 | Adjuvant (A) | 2014-03-20 | 2014-04-14 | Cetuximab + Radiotherapy Load | N | Y | 270020036 | RUXOLITINIB |
| 270009674 | 270005717 | 1.63 | null | Curative (C) | null | 2016-03-20 | Brentuximab | N | N | 270020036 | AZACITIDINE |
| 270009675 | 270005717 | 1.75 | 51.6 | Palliative (P) | 2017-12-03 | 2017-12-13 | CAP + RT | N | N | 270020036 | CETUXIMAB + RT |
| 270009676 | 270019478 | null | null | Neo-adjuvant (N) | 2013-07-12 | 2013-07-15 | Docetaxel 100mg/m2 (21 day) | N | N | 270020051 | CARBOPLATIN |
| 270009677 | 270005718 | 1.63 | 105 | Curative (C) | 2015-08-17 | 2015-08-23 | OXALIPLATIN | N | N | 270020058 | MITOMYCIN INTRAVESICULAR |
| 270009678 | 270005719 | 1.68 | 89.4 | Palliative (P) | 2014-01-07 | 2014-01-16 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 270020060 | CAPE + CARBOPLATIN + CETUXIMAB |
| 270009679 | 270005720 | 1.7 | 88 | Curative (C) | 2016-02-03 | 2016-02-11 | CARBOPLATIN + PACLITAXEL + RT | N | N | 270020062 | SCOT TRIAL |
| 270009680 | 270005721 | 1.73 | 86.6 | Palliative (P) | 2017-09-26 | 2017-10-06 | CAPECITABINE + TEMOZOLOMIDE | Y | N | 270020071 | CETUXIMAB + IRINOTECAN + MDG |
| 270009681 | 270005722 | 1.6 | 48.7 | Curative (C) | 2016-06-07 | 2018-01-27 | CETUXIMAB + RT | N | N | 270020073 | CARBOPLATIN |
| 270009682 | 270005723 | 1.7 | null | Palliative (P) | 2016-09-22 | 2016-09-29 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270020076 | FLUOROURACIL + MITOMYCIN + RT |
| 270009683 | 270005724 | 1.82 | 47.8 | Palliative (P) | 2017-04-08 | 2017-06-01 | Enzalutamide | 2 | N | 270020093 | GEMCARBO |
| 270009684 | 270005724 | null | 63.5 | Palliative (P) | null | 2017-01-31 | CVP R | N | N | 270020093 | CETUXIMAB |
| 270009686 | 270005725 | 1.75 | 21.5 | null | 2017-03-22 | 2017-04-05 | Carboplatin AUC 6 - 10 | N | N | 270020109 | CARBOPLATIN + ETOPOSIDE |
| 270009687 | 270005726 | 1.74 | 70.8 | Adjuvant (A) | 2013-05-05 | 2013-05-05 | Carboplatin AUC 6 - 10 | 2 | Y | 270020111 | CAP + RT |
| 270009688 | 270005727 | 1.72 | 69.4 | Palliative (P) | 2016-09-25 | 2016-10-12 | CETUXIMAB + IRINOTECAN | null | null | 270020117 | ENZALUTAMIDE |
| 270009689 | 270005727 | 1.57 | 75 | Curative (C) | 2015-01-17 | 2015-03-13 | Carboplatin AUC 6 - 10 | 02 | N | 270020117 | CARBO + FLUOROURACIL |
| 270009690 | 270005727 | null | null | Palliative (P) | 2015-02-08 | 2015-02-17 | Cetuximab 14 day | 02 | N | 270020117 | CETUXIMAB |
| 270009691 | 270005727 | 1.78 | 69.7 | Curative (C) | 2013-09-24 | 2013-09-25 | Imatinib 400mg | 02 | N | 270020117 | CARBOPLATIN + RT |
| 270009692 | 270005727 | 1.79 | 80.8 | Adjuvant (A) | 2014-12-31 | 2015-01-21 | Cetuximab + Radiotherapy Maint | N | Y | 270020117 | CARBOPLATIN + PEMETREXED |
| 270009693 | 270005727 | 1.76 | 85 | Curative (C) | 2014-08-02 | 2014-08-27 | CETUXIMAB + RT | Y | N | 270020117 | CETUXIMAB + RT |
| 270009694 | 270005727 | null | 102.5 | Palliative (P) | 2013-09-03 | 2013-09-28 | Bevacizumab 5mg/kg | 99 | null | 270020117 | CAPECITABINE + IRINOTECAN |
| 270009695 | 270020009 | 1.62 | 77 | Curative (C) | 2016-05-12 | 2016-05-21 | CETUXIMAB + RT | N | N | 270020174 | NOT MATCHED |
| 270009696 | 270005728 | 1.8 | 52 | Neo-adjuvant (N) | 2018-01-01 | 2018-01-17 | GEMCITABINE | N | N | 270020188 | CARBOPLATIN |
| 270009697 | 270005729 | 1.63 | 68 | Adjuvant (A) | null | 2017-06-29 | Mitomycin Intravesical | null | null | 270020201 | CARBOPLATIN |
| 270009698 | 270005730 | 1.64 | 53.9 | Palliative (P) | 2017-11-16 | 2017-11-16 | LOPP | 02 | N | 270020205 | CETUXIMAB |
| 270009699 | 270012826 | 0 | 62.9 | Curative (C) | 2014-03-31 | 2014-04-13 | Carboplatin AUC 2 - 5 | 02 | null | 270020206 | SCOT TRIAL |